Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.30 (
PARP
)
13,611
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tankyrase 1 is a poly(ADP-ribose) polymerase (
PARP
) that participates in a broad range of cellular activities due to interaction with multiple binding partners. Tankyrase 1 recognizes a linear six-amino-acid degenerate motif and, hence, has hundreds of potential target proteins. Binding of partner proteins to tankyrase 1 usually results in their poly(ADP-ribosyl)ation (PARsylation) and can lead to ubiquitylation and proteasomal degradation. However, it is not known how tankyrase 1
PARP
activity is regulated. Here we identify
GDP-mannose 4,6-dehydratase
(
GMD
) as a binding partner of tankyrase 1.
GMD
is a cytosolic protein required for the first step of fucose synthesis. We show that
GMD
is complexed to tankyrase 1 in the cytosol throughout interphase, but its association with tankyrase 1 is reduced upon entry into mitosis, when tankyrase 1 binds to its other partners TRF1 (at telomeres) and NuMA (at spindle poles). In contrast to other binding partners,
GMD
is not PARsylated by tankyrase 1. Indeed, we show that
GMD
inhibits tankyrase 1
PARP
activity in vitro, dependent on the
GMD
tankyrase 1 binding motif. In vivo, depletion of
GMD
led to degradation of tankyrase 1, dependent on the catalytic
PARP
activity of tankyrase 1. We speculate that association of tankyrase 1 with
GMD
in the cytosol sequesters tankyrase 1 in an inactive stable form that can be tapped by other target proteins as needed.
...
PMID:GDP-mannose-4,6-dehydratase is a cytosolic partner of tankyrase 1 that inhibits its poly(ADP-ribose) polymerase activity. 2264 5
Human tankyrase-1 (TNKS) is a member of the poly(ADP-ribose) polymerase (
PARP
) superfamily of proteins that posttranslationally modify themselves and target proteins with ADP-ribose (termed PARylation). The TNKS ankyrin repeat domain mediates interactions with a growing number of structurally and functionally diverse binding partners, linking TNKS activity to multiple critical cell processes, including Wnt signaling, Golgi trafficking, and telomere maintenance. However, some binding partners can engage TNKS without being modified, suggesting that separate parameters influence TNKS interaction and PARylation. Here, we present an analysis of the sequence and structural features governing TNKS interactions with two model binding partners: the PARylated partner telomeric repeat-binding factor 1 (TRF1) and the non-PARylated partner
GDP-mannose 4,6-dehydratase
(
GMD
). Using a combination of TNKS-binding assays,
PARP
activity assays, and analytical ultracentrifugation sedimentation analysis, we found that both the specific sequence of a given TNKS-binding peptide motif and the quaternary structure of individual binding partners play important roles in TNKS interactions. We demonstrate that
GMD
forms stable 1:1 complexes with the TNKS ankyrin repeat domain; yet, consistent with results from previous studies, we were unable to detect
GMD
modification. We also report
in vitro
evidence that TNKS primarily directs PAR modification to glutamate/aspartate residues. Our results suggest that TNKS-binding partners possess unique sequence and structural features that control binding and PARylation. Ultimately, our findings highlight the binding partner:ankyrin repeat domain interface as a viable target for inhibition of TNKS activity.
...
PMID:Structural and functional analysis of parameters governing tankyrase-1 interaction with telomeric repeat-binding factor 1 and GDP-mannose 4,6-dehydratase. 3137 64